Introduction peroxide bridge is the essential pharmacophore for biological activity, medicinal chemists have developed a range of Peroxides represent a new chemical class of antimalarial drugs ( Figure 1 ). The first generation compounds are all second generation derivatives. Representative compounds include the bicyclic fenozan type derivatives, synthesized by derivatives of artemisinin, the active principle of a Chinese herbal remedy [1] . Artemisinin, or qinghaosu (green plant Jefford et al. [9] , the tetroxanes synthesized by Vennerstrom [10] and tricyclic simplified derivatives prepared by Posner extract), is extracted from Artemesia annua, a plant which grows widely in South China. The first generation comand coworkers [11] . The discovery that several of the first generation artemisinin derivatives are metabolised extensively pounds currently in use are derivatives of the lactol, dihydroartemisinin, which is a major metabolite for each of to DHA has prompted other workers to prepare C-10-carba deoxy derivatives (for a review see Meshnick et al. [1] ). the derivatives, and may be the most important chemical species for antimalarial activity in vivo. The promise of these These compounds cannot be metabolised to DHA, which undergoes fairly rapid clearance [8] , and should therefore compounds lies in their effectiveness against chloroquineresistant parasites and their rapid action against malaria.
have longer half-lives in vivo.
The initial focus of the medicinal chemist is clearly Moreover, they have been used for the treatment of malaria in three million patients with few reports of clinically directed towards the discovery of simpler (hence often less expensive) and more potent compounds, which provides significant toxicity [2] .
The drawback with artemisinin and related compounds is not only lead compounds for therapeutic use, but also pharmacological tools to define the mechanism of action of that they suffer from poor bioavailability: the relative bioavailability of oral artemisinin (vs intramuscular) and this class of agent and the essential pharmacophore. A QSAR study of antimalarial activity indicates that docking intramuscular artemether (vs oral) and the bioavailability of artesunate are all within a range of 15-30% [3] [4] [5] . This may between an active trioxane and the receptor, haem, could be the crucial step preliminary to drug action [12] . be one of the reasons for the relatively high rate of recrudescence associated with peroxide monotherapy. Their Drug safety is an important consideration which has to be evaluated in concert with efficacy at the earliest possible complex chemical structures are not essential for pharmacological activity and there has, therefore, been a drive to design stage in drug development. It is therefore essential to define the potential hazards associated with second or third generand synthesize simpler endoperoxides which have greater in vivo potency. To date, more than 1000 new endoperoxides ation peroxides that present greater and more prolonged systemic exposure and design appropriate test systems for belonging to several chemical classes have been prepared. A number of 'second generation' peroxides have been develscreening for drug toxicity. The specific questions which need to be addressed during further chemical development oped, including arteflene ( Figure 1 ). This is a synthetic peroxide developed from yingzhaosu A, the complex active of peroxide antimalarials are as follows. Will such chemical modifications lead to loss of the high constituent of the Chinese plant Artabotrys uncinatus, after it was shown to have antimalarial activity [6] . It has been degree of selective therapeutic potency noted for first generation peroxide antimalarials? tested in clinical trials in Africa.
The 'first generation' artemisinin derivatives, as described Will chemical modification result in greater exposure of mammalian systems to hazards posed by the peroxide group above, are chemically simple esters and ethers of the parent lactol, dihydroartemisinin ( Figure 1 ) [7, 8] . These comsuch as the neurotoxicity observed in rodents given first generation peroxides? pounds are generally more potent than artemisinin both in vitro and in vivo, and provide a wider choice of formulations
The purpose of this review is to address each of these questions from chemical and clinical perspectives. which are more easily administered to patients in the field. Artemether and arteether are more oil soluble than artemisinin and are currently undergoing clinical trials under WHO Clinical efficacy and safety sponsorship [8] . Other first generation derivatives include Numerous studies have shown that artemisinin compounds sodium artesunate, the DHA b-O-succinate half ester sodium have several advantages over other antimalarial drugs: these salt, and sodium artelinate, the corresponding DHA b-O-pinclude the more rapid clearance of parasites in the periphery carboxybenzyl ether sodium salt. Both of these compounds, [2] , more rapid resolution of fever [13, 14] , and a reduction which are water soluble, are currently under investigation in the transmission potential of falciparum malaria [15] . as intravenous treatments for severe malarial infections [8] .
Despite these apparent advantages, no study has yet shown Given the obvious pharmacokinetic limitations of the a beneficial effect of artemisinin compounds on survival, although this may largely be due to the fact that most Figure 1 Chemical structures of 'First' and 'Second' generation peroxides. The fenozan, tetroxane and tricyclic trioxanes are totally synthetic compounds prepared from readily available starting materials. The first generation DHA derivatives and the carba derivatives (e.g. C-10-Carba) are compounds prepared directly by manipulation of the parent drug artemisinin. differences in mortality [16] . Importantly, the peroxides are Despite their extensive use, there have been very few reports of clinically significant toxicity with the peroxide effective against Plasmodium falciparum strains resistant to other antimalarials [17] , and there have been no reports of antimalarials. Minor gastro-intestinal adverse effects such as nausea, diarrhoea and abdominal pain have been reported in parasite resistance [2, 7] .
The artemisinin compounds have become first-line drugs some patients; tenesmus occurs in 6% of patients administered artemisinin suppositories [2] . Transient increases in serum in several regions in South-east Asia. The main clinical disadvantage of artemisinin and its derivatives is the high transaminases, and decreases in the reticulocyte and neutrophil counts have also been encountered, but these have rate of recrudescence when compared with other antimalarials [2] ; the reasons for this are unclear, but partly reflect been of little clinical significance [2] . There have also been isolated reports of rash but a causal association was unlikely the low bioavailability and short half-lives of these compounds. In addition, it has been found that artemisinin areas [20] . Interestingly, 25% of volunteers receiving artemisinin had an episode of drug-induced fever [2, 16] in some under the plasma concentration curves decrease during repeated drug administration, indicating that auto-induction studies, though the significance of this is unclear.
Given that cardiotoxicity is a potential worry with many of hepatic drug-metabolising enzymes may contribute to incomplete parasite clearance [18] . In vivo potency with of the antimalarial drugs [21] , and QT prolongation has been reported in animals treated with artemether [2] , many respect to parasite elimination is also a problem with second generation peroxides. A comparison of single dose therapies of the clinical studies have actively monitored for potential cardiotoxicity. To date, most of the abnormalities detected in children with uncomplicated P. falciparum malaria in Gabon showed that arteflene was ineffective in contrast to have been minor and of little clinical significance. For example, transient first-degree heart block was noted in 1 mefloquine, which proved to be highly effective [19] . of 82 patients receiving artesunate, and 3 of 39 patients complex 1,2,4-trioxane structure. A comparison with the second generation peroxides indicates that the 1,2,4-trioxane receiving artemether [2] . In a recent study, it was demonstrated that 25% of 284 adults treated with intramuscular structure per se is not essential for pharmacological activity in the parasite, although it has not yet been established artemether for severe falciparum malaria had a QTc interval of more than 0.5 s [22] . However, it is possible that this was whether the overall structure provides (a) 'protection' for the host by restricting the intracellular (e.g. in the nervous caused by the disease rather than the treatment [23] .
Given the findings in animals (see below), the major system) bioactivation of the peroxide, and (b) alternative routes of metabolism in man (i.e. direct detoxication). concern with this class of compounds has been their potential to cause neurotoxicity. Clinical trials to date have not Artemether undergoes several hydroxylations in vivo, most of which lead to a decrease in pharmacological activity [32] . identified any cases of neurotoxicity [2] which can definitely be attributed to the artemisinin compounds. However, the Dihydroartemisinin undergoes extensive glucuronidation [33] , which again results in loss of activity [34] . recent reports of a prolonged length of time to recovery from coma (when compared with patients treated with
The parasite digests haemoglobin to obtain amino acids but releases haem, a potentially toxic species ( Figure 3 ). quinine) in Vietnamese [22] and Gambian [24] patients, and an increased frequency of seizures in artemether-treated
Haem is detoxified in the parasite by the formation of a nontoxic but not entirely unreactive polymer, the malaria patients in Gambia [24] , have raised concerns of the neurotoxic potential of these compounds [25] . In addition, pigment, haemozoin. Free haem catalyses the conversion of peroxides into free radicals and other electrophilic intermedithere has recently been one report of the occurrence of an acute cerebellar syndrome in a 36-year-old previously ates which alkylate haem and specific parasite proteins, and thereby it is supposed, kill the parasite [35, 36] . As well as healthy man after five doses of artesunate, the features of which were still present (although improved) 4 months later the formation of carbon-centred radicals there is also the formation of a high valent iron-oxo species (Fe
Clearly, one such report does not constitute proof of a causal association [27] , but the possibility that repeated ( Figure 4 ).
In vitro studies have shown that all endoperoxide administration of artemisinin compounds in malaria endemic areas will result in cumulative damage cannot be ruled out antimalarial compounds share common targets with respect to protein alkylation [35] . It has been demonstrated that [2, 28] , especially since these drugs are often freely available for use in tropical countries [29] . Another possibility that dihydroartemisinin associates with parasite membranes, haemozoin and mitochondria; damage occurs in the mitocannot be discounted at this stage is that some patients may have suffered subclinical neurological toxicity which would chondria, rough endoplasmic reticulum and the nuclear envelope, and there are also changes in the nucleus, have required sophisticated neurological and neuropsychological tests for detection. The potential of the drugs to ribosomes and food vacuole [36] . Antioxidants such as catalase, dithiothreitol and acause neurotoxicity is discussed in greater detail below.
Fear of potential toxicity has limited the use of the tocopherol have been shown to antagonise the antimalarial action of artemisinin [37] . The role of iron was defined in artemisinin derivatives in pregnancy since animal studies have documented teratogenicity when the drugs are experiments which showed that iron chelators antagonise the antimalarial activity of an artemisinin derivative, administered at high doses [30] . At present documentation of the safety of artemisinin derivatives in the treatment of arteether [38] . malaria in pregnant women is limited and it has therefore been recommended that these drugs should be used in Toxicology in animal models pregnancy only as a last resort [31] .
Thus, there is a need to develop better peroxide Undoubtedly the major concern raised by preclinical studies in animals is that of the neurotoxicity which has been compounds, the ideal properties of which would be (a) a pharmacological profile which allows for shorter durations observed in rats, dogs [39, 40] and more recently in monkeys [41] . It seems to be dose-dependent and has occurred at of treatment with fewer doses, (b) greater bioavailability to ensure sufficient parasite exposure, (c) a predictable pharmrelatively high doses (20-50 mg kg −1 day −1 ); the currently recommended dose for both artemether and artesunate in acokinetic profile such that the drug is retained for sufficient lengths of time to ensure that it kills the parasites, but does man is 10 mg kg −1 day −1 . However, relative systemic exposure to drug in man and in the animal models has not not accumulate to any extent to cause damage to the host, (d) low interindividual pharmacokinetic variability and (e) been determined. A progressive syndrome of clinical neurological deficits with cardio-respiratory collapse (with lack of toxicity. Rational molecular design must be based on both structure-activity and structure-toxicity/metabolism prolongation of the QT c interval) and death was noted in dogs dosed for 8 days with arteether (20 mg kg −1 ). relationships.
Prominent neuropathologic lesions were limited to the pons and the medulla [39] . In the rat, brain stem histological Mechanism of action of peroxide antimalarials: role of lesions have been seen in the absence of neurologic signs or parasite bioactivation deficits in behavioural performance [1] . Toxicity has been confirmed in vitro in Neu2a neuroblastoma cells; these cells The essential chemical features required for pharmacological activity are simply a peroxide moiety, which is sterically took up much less dihydroartemisinin than P. falciparuminfected red blood cells, suggesting that the compounds may hindered, and in the case of many second generation peroxides a lipophilic aromatic ring system (Figures 1 and show selective toxicity for the parasite in vivo. As pointed out earlier, despite many years of use there is little evidence 2). Artemisinin contains a peroxide bridge within a more q Parasite detoxifies haem by polymerisation to non-toxic haemozoin (malaria pigment).
q In spite of haem monomer polymerisation there is still sufficient quantities to catalyse isomerisation of artemisinin into oxyl and Ccentred radicals which kill the parasite.
Figure 3
General scheme for the mechanism of action of antimalarial peroxides. The critical step for activity of the drug is believed to be the formation of a C-centred radical that is proposed to kill the parasite by alkylation. Figure 4 Chemical details of the iron-mediated bioactivation reactions of artemisinin that are believed to be critical for antimalarial activity. At the top of the scheme, the initially formed oxyl radical rearranges by a 1,5-H shift to produce a C-centred radical that is then ultimately transformed into the hydroxy deoxy derivative (HODEOXART) as shown. Note that this pathway may also produce a high valent Fe(IV)O species which is proposed to oxidatively damage cellular macromolecules [52] . At the bottom of the scheme, association of Fe(II) with O1 and scission of the alkyl bond produces a primary radical, which in the absence of a protein or porphyrin acceptor is further transformed into the THF-acetate derivative as shown.
of neurotoxicity in man. An opportunistic postmortem [48] . The antioxidants ascorbic acid and glutathione afforded protection against the toxicity. examination of the brain stem of a patient who took singledose artesunate showed no abnormalities [42] .
Although it is thought that products of iron-catalysed bioactivation are responsible for both the parasite and Artemisinin derivatives have been shown to be toxic to neuroblastoma cells in vitro, as measured by either radiolabelmammalian toxicity of peroxides, it is also possible that the radicals might damage iron-containing proteins and thereby led precursor incorporation or neurite outgrowth. Toxicity is specific to neuronal cells and does not affect glial cells release iron which could be a cause of oxidative damage [49] . Iron is thought to be a crucial factor in reactive oxygen [43] . Structure-toxicity relationships indicate that the chemistry of the d-ring is an important determinant of in vitro metabolite-induced cytotoxicity. In order to induce lipid peroxidation, superoxide and/or hydrogen peroxide must toxicity, with dihydroartemisinin being considerably more toxic than other derivatives [43, 44] [45] .
Arteflene ( Figure 1 ) is a synthetic peroxide which, as Thus, it is possible that the disposition of iron at both the mentioned earlier, was brought forward for preclinical and cellular and molecular levels might be intimately involved clinical evaluation from a series of yingzhaosu A derivatives in the bioactivation of peroxides and their subsequent [6] . The compound was selected on the basis of its greater biological effects. chemical stability than artemisinin and thus its anticipated improved pharmacokinetic properties. Arteflene was found Biomimetic Fe(II) catalysed reactions and biomarkers to be negative in a battery of mutagenicity tests and did not of bioactivation produce any neurotoxicity when given in high doses to dogs (up to 700 mg kg −1 ). However, reproductive studies As mentioned earlier, the malaria parasite Plasmodium falciparum, in the intraerythrocytic stage of its life cycle, revealed clear embryolethal effects (37-57% intrauterine deaths) in rats at 20 mg kg −1 and a slight effect in rabbits at digests haemoglobin, which results in the generation of ferriprotoporphyrin IX (haem). Since 'free haem' is toxic to 40 mg kg −1 . Autopsy examination of the foetus showed the presence of blood vessel anomalies and fused sternebrae in the parasite, it is normally removed by polymerization to haemozoin, an insoluble pigment. A number of model the 20 mg kg −1 dose group [30] . The embryotoxicity was comparable with the effects seen with artemisinin. Pregnant studies utilizing iron (II) salts and haem iron (II) have been reported for artemisinin [36] with several intermediates rats given extremely high doses (up to 3000 mg kg −1 ) of artemisinin within 6 days of gestation had normal foetuses; being proposed as the ultimate cytotoxic species (Figure 4) . Association of either of the peroxide oxygens in the trioxane however, the drug caused foetal death and resorptions in rodents, even at relatively low doses when given after the skeleton produces oxyl radicals that can either participate in a 1,5-H-shift or carbon C-C bond scission to produce a sixth day of gestation [46, 47] . There was no evidence of teratogenicity in the offspring that survived organogenesis.
carbon-centred radical species. Also implicated in the mechanism of action of artemisinin is the formation of a No such abnormalities have been reported in man, but the safety data are extremely limited More recently, we have proposed a mechanism of action for arteflene based on similar mechanistic studies using Fe(II) preclude the use of these compounds for prophylaxis in women unless specific contraceptive precautions are salts [53] . Arteflene, on reaction with FeCl 2 .4H 2 O, yielded two products, the two-electron reduction diol product and undertaken.
The acute toxicity of artemisinin in mice which involves the enone, a surrogate marker for the formation of the cyclohexyl radical ( Figure 5 ). the gastrointestinal tract is antagonised by an iron chelator [38] , indicating a role for iron-catalysed bioactivation of the The formation of the THF acetate from artemisinin and the enone products from arteflene may be effective surrogate peroxide group. This may reflect the availability of free iron in the gut. However, the role for peroxide bioactivation in markers of bioactivation. However, further work is required to determine whether the generation of these entities in a particular, and metabolism in general, in chronic toxicity (neurotoxicity and reproductive toxicity) is not known.
mammalian system leads to radical-induced toxicity. In theory, such radicals might cause toxicity which would be Since neurotoxicity is not observed with arteflene [6], this would suggest that the toxicity when observed after partly determined by the availability of iron (II) and its tissue distribution. administration of artemisinin and its derivatives is not simply a function of the presence of a peroxide group. In vitro Two distinct (but not exclusive) mechanisms for the ironmediated activation of peroxides in mammalian tissues are studies with neuroblastoma cells have shown that ironcatalysed activation of artemether significantly enhances the envisaged. Firstly, simple nonenzymic reactions, involving free iron and/or iron bound to protein, although the neurotoxicity of artemether with concomitant formation of a rearrangement product, artemether tetrahydrofuran acetate chemical reactivity of peroxides with iron associated with, Figure 5 Proposed mechanism of action of arteflene [53] . Arteflene by Fe(II)-mediated one-electron reduction can produce a C-centred radical and a potentially toxic a,b-unsaturated enone. This enone, if generated in the parasite food vacuole, might act as a Michael acceptor of thiols. The enone product, in effect, is a surrogate marker of bioactivation. Ar=2, 4-bistrifluoromethyl benzene.
for example, transferrin has not been defined. Secondly, findings in animals by normal pharmacokinetic analysis was precluded. Furthermore, the importance of development reactions catalysed by haemthiolate enzymes, and specifically by the microsomal cytochrome P450 enzymes [54] and the age and disease with respect to toxicological risk had not been defined. prostacyclin and thromboxane synthases [55] . The synthases, in particular, catalyse isomerizations of endogenous prostagRecently, specific and sensitive h.p.l.c. and LC-MS methods [3, 33, 57] have been developed for the analysis of landin H 2 endoperoxide which are analogous in detail to the iron-mediated isomerizations of artemisinin.
artemisinin and related compounds in plasma, and for the characterization and quantification of metabolites. Following intravenous administration, artesunate is rapidly (t 1/2 3 min) Disposition of peroxides in relation to human safety hydrolysed to dihydroartemisinin which in turn has a relatively short half-life of only 40 min [4] . In both the rat The main safety concern for present and future peroxide antimalarials is whether the peroxide pharmacophore can [33] and man (Maggs et al. unpublished) , the principal pathway of metabolism for dihydroartemisinin ( Figure 6 ) is act as a toxicophore and if so, under what circumstances could this occur. At present, little is known about the glucuronidation. It is possible that the rate of glucuronidation may serve to limit the therapeutic effectiveness of the drug metabolic fate of peroxides. Important questions which need to be addressed are:-with respect to disease recrudescence, as glucuronides are inactive [34] , but it may also preclude the neurotoxicity does the peroxide group per se undergo a direct detoxication biotransformation in mammalian systems?
observed with high doses of first generation peroxides in the rat and dog by preventing isomerization of DHA to does the peroxide bridge undergo bioactivation in vivo in mammalian cells? neurotoxic products. Further studies are required to test this hypothesis. In addition, glucuronidation serves to trap the what are the biological consequences of bioactivation? is the development of peroxides with longer half-lives, unstable lactol moiety, in a chemical sense, and thus prevents the rearrangement of the unstable dihydroartemisinin to for more sustained antimalarial activity, likely to be associated with a greater risk of toxicity? ketone intermediates which are potentially neurotoxic (although so far only observed in in vitro systems). There is can prolonged exposure to free radicals exhaust the scavenging or repair systems resulting in host cell damage no evidence for detoxication of the peroxide group per se, by reduction, for example, as has been described for and if so, can drugs with longer half-lives be (clinically) more toxic?
prostaglandin peroxides [58] . A key question is whether bioactivation of peroxides In order to address these issues, it is necessary to define all the major and minor routes of metabolism. Of particular catalysed by iron occurs in vivo during therapeutic administration. The body takes great care to safely sequester iron relevance are metabolites (including rearrangement products and fragments) which indicate bioactivation of the peroxide and copper in non or poorly reactive forms [59] ; the body store is divided between essential iron-containing comgroup; and also metabolites which signal the formation of potentially toxic species such as aldehydes and enones.
pounds and excess iron which is held in storage [60] . Iron disposition is extremely tightly controlled, with only 10% However, peroxide antimalarials were introduced into clinical use without any formal knowledge of either of total stores being excreted per year. The major form of essential iron is haemoglobin, although there are a variety disposition or metabolism [56] because of the lack of suitable analytical techniques. Thus, assessment of the risk to man of of haem-dependent enzymes including the cytochrome P450 family. Ferritin is the intracellular storage protein, and relatively high during neonatal development in the rat [63] . There is thus circumstantial evidence to relate the disposition may contain 4000 atoms of iron (III) per ferritin molecule. Aggregated ferritin (haemosiderin) constitutes about one of iron to the two major toxicities observed in vivo, neurotoxicity and embryotoxicity. third of normal stores. The two predominant sites of iron storage are hepatocytes and the reticuloendothelial system.
The key questions that must be answered with respect to safety evaluation are: Internal distribution and disposition of iron is facilitated by the plasma protein transferrin, which has two binding sites does peroxide bioactivation cause toxicity in man, including neurotoxicity and reproductive toxicity? for ferric iron. Iron is delivered to intracellular sites via specific transferrin receptors and subsequent endocytosis;
is there species variation in the bioactivation of peroxides? are there species differences in the detoxication of iron is then released in the endosome.
Iron can catalyse the rapid bioactivation of all peroxide peroxides? Evidence for peroxide bioactivation in vivo can be obtained antimalarials to chemically reactive radical intermediates [36] . However, this ability depends upon the regeneration by using specific metabolites as biomarkers. Parallel in vitro studies can be performed to define the role of disposition in of iron (II), which may be prevented by binding of Fe(III) to a carrier protein [49] . Iron complexed to haem also toxicity and the chemical species which is responsible. Such information would allow extrapolation of the toxicities catalyses the bioactivation of peroxide antimalarials [53] , and this activity appears to be preserved in haemothiolate observed in animals to man. enzymes [55] . In contrast, cytochrome P450 enzymes can effect the hydroxylation of either artemisinin or arteflene at Conclusions a site close (<2 A°) to the peroxide bridge without necessarily activating the peroxide bridge [54] . Incubation Malaria remains a major health problem world-wide, with more than 200 million people infected at any time and at of haemoglobin with organic peroxides releases iron [59] .
Ferritin contains the greatest part of iron found in the least one million deaths annually. Chloroquine has been a cheap and effective treatment for malaria for several decades brain, and the release of iron stores from ferritin has an essential role in iron-dependent lipid peroxidation.
but there is now widespread resistance to this and newer antimalarials such as halofantrine and mefloquine. Stimulation of cultured microglia by phorbol myristate acetate causes both iron mobilization and superoxide Peroxides are an important new chemical class of antimalarials which are at present undergoing extensive production [61] . It has been postulated that such iron release may be partly responsible for neurodegenerative disorders clinical evaluation and further chemical development. No major forms of human toxicity have been detected for the such as Parkinson's disease. Histochemical studies have shown that there is considerable variation in the iron content peroxides, although assessment of long-term human safety is limited by a situation in which the clinical use of the throughout the brain, and there is also interspecies variation in transferrin levels [62] . Interestingly, it has been shown drug is not accompanied by the standard practice of postmarketing surveillance. The concern over long-term that both iron uptake and the iron concentration are 
